{"data":[{"accessionNo":"0002012383-26-003917","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":717813,"percentOfClass":4.9,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001172661-26-003427","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BALYASNY ASSET MANAGEMENT L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":951783,"percentOfClass":6.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001172661-26-003427","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BAM GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":951783,"percentOfClass":6.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001172661-26-003427","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Balyasny Asset Management Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":951783,"percentOfClass":6.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001172661-26-003427","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Dames GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":951783,"percentOfClass":6.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001172661-26-003427","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Dmitry Balyasny","reportingCik":null,"personType":"HC,IN","sharesOwned":951783,"percentOfClass":6.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001708269-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-24","reportingPerson":"Atlas Venture Fund XI, L.P.","reportingCik":"0001708269","personType":"PN","sharesOwned":706556,"percentOfClass":4.9,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001708269-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-24","reportingPerson":"Atlas Venture Associates XI, L.P.","reportingCik":"0001780068","personType":"PN","sharesOwned":706556,"percentOfClass":4.9,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001708269-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-24","reportingPerson":"Atlas Venture Associates XI, LLC","reportingCik":"0001780067","personType":"OO","sharesOwned":706556,"percentOfClass":4.9,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001708269-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-24","reportingPerson":"Atlas Venture Opportunity Fund II, L.P.","reportingCik":"0001885327","personType":"PN","sharesOwned":146305,"percentOfClass":1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001708269-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-24","reportingPerson":"Atlas Venture Associates Opportunity II, L.P.","reportingCik":"0001935814","personType":"PN","sharesOwned":146305,"percentOfClass":1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001708269-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-24","reportingPerson":"Atlas Venture Associates Opportunity II, LLC","reportingCik":"0001935810","personType":"OO","sharesOwned":146305,"percentOfClass":1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0002012383-26-002892","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":747546,"percentOfClass":5.2,"filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000919574-26-003500","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":276831,"percentOfClass":1.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000919574-26-003500","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"72 Investment Holdings, LLC","reportingCik":null,"personType":"OO","sharesOwned":276831,"percentOfClass":1.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000919574-26-003500","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Differentiated Ventures Investments, LLC","reportingCik":null,"personType":"OO","sharesOwned":276831,"percentOfClass":1.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000919574-26-003500","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Biotech Private Investments, LLC","reportingCik":null,"personType":"OO","sharesOwned":276831,"percentOfClass":1.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000919574-26-003500","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000919574-26-003500","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001846","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Lynx1 Capital Management LP","reportingCik":null,"personType":"PN","sharesOwned":1538296,"percentOfClass":10.7,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001846","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Weston Nichols","reportingCik":null,"personType":"IN","sharesOwned":1538296,"percentOfClass":10.7,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000102909-26-001615","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio Inc","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001104659-26-029468","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1488685,"percentOfClass":9.9,"filedAt":"2026-03-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001104659-26-029468","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":1488685,"percentOfClass":9.9,"filedAt":"2026-03-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001104659-26-029468","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1488685,"percentOfClass":9.9,"filedAt":"2026-03-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001104659-26-029468","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":1488685,"percentOfClass":9.9,"filedAt":"2026-03-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001104659-26-029468","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":1488685,"percentOfClass":9.9,"filedAt":"2026-03-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001104659-26-029468","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":1488685,"percentOfClass":9.9,"filedAt":"2026-03-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001104659-26-029468","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":"500946108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":1488685,"percentOfClass":9.9,"filedAt":"2026-03-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001072613-26-000267","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"New Enterprise Associates 17, L.P.","reportingCik":"0001768564","personType":"PN","sharesOwned":1435487,"percentOfClass":9.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001072613-26-000267","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"NEA Partners 17, L.P.","reportingCik":"0001796820","personType":"PN","sharesOwned":1435487,"percentOfClass":9.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001072613-26-000267","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"NEA 17 GP, LLC","reportingCik":"0001796821","personType":"OO","sharesOwned":1435487,"percentOfClass":9.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001072613-26-000267","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Forest Baskett","reportingCik":"0001277631","personType":"IN","sharesOwned":1435487,"percentOfClass":9.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001072613-26-000267","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Ali Behbahani","reportingCik":"0001613867","personType":"IN","sharesOwned":1456677,"percentOfClass":9.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001072613-26-000267","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Carmen Chang","reportingCik":"0001746342","personType":"IN","sharesOwned":1435487,"percentOfClass":9.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001072613-26-000267","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Anthony A. Florence, Jr.","reportingCik":"0001559827","personType":"IN","sharesOwned":1435487,"percentOfClass":9.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001072613-26-000267","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Mohamad H. Makhzoumi","reportingCik":"0001630226","personType":"IN","sharesOwned":1435487,"percentOfClass":9.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001072613-26-000267","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Edward T. Mathers","reportingCik":"0001328625","personType":"IN","sharesOwned":1435487,"percentOfClass":9.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001072613-26-000267","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Scott D. Sandell","reportingCik":"0001237289","personType":"IN","sharesOwned":1435487,"percentOfClass":9.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001072613-26-000267","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Paul Walker","reportingCik":"0001553150","personType":"IN","sharesOwned":1435487,"percentOfClass":9.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001072613-26-000267","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Rick Yang","reportingCik":"0001851328","personType":"IN","sharesOwned":1435487,"percentOfClass":9.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001559","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":816885,"percentOfClass":5.7,"filedAt":"2026-03-11","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001559","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":540054,"percentOfClass":3.7,"filedAt":"2026-03-11","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001559","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":540054,"percentOfClass":3.7,"filedAt":"2026-03-11","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001559","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Point72 Biotech Private Investments, LLC","reportingCik":null,"personType":"OO","sharesOwned":276831,"percentOfClass":1.9,"filedAt":"2026-03-11","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001559","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"Differentiated Ventures Investments, LLC","reportingCik":null,"personType":"OO","sharesOwned":276831,"percentOfClass":1.9,"filedAt":"2026-03-11","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001559","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-10","reportingPerson":"72 Investment Holdings, LLC","reportingCik":null,"personType":"OO","sharesOwned":276831,"percentOfClass":1.9,"filedAt":"2026-03-11","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001135","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"72 Investment Holdings, LLC","reportingCik":null,"personType":"OO","sharesOwned":276831,"percentOfClass":2.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001135","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Biotech Private Investments, LLC","reportingCik":null,"personType":"OO","sharesOwned":276831,"percentOfClass":2.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001135","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Differentiated Ventures Investments, LLC","reportingCik":null,"personType":"OO","sharesOwned":276831,"percentOfClass":2.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001135","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":276831,"percentOfClass":2.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001135","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000938206-26-000004","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"DRIEHAUS CAPITAL MANAGEMENT LLC","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-001135","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001104659-26-015339","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":600000,"percentOfClass":6.37,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001104659-26-015339","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":600000,"percentOfClass":6.37,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0001104659-26-015339","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":600000,"percentOfClass":6.37,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000315066-26-000455","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"KORRO BIO INC","ticker":"KRRO","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":37857,"percentOfClass":0.4,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000315066-26-000455","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001703647","issuerName":"KORRO BIO INC","ticker":"KRRO","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":37857,"percentOfClass":0.4,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000102909-26-000315","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio Inc","ticker":"KRRO","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":489639,"percentOfClass":5.19,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-000037","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-23","reportingPerson":"Lynx1 Capital Management LP","reportingCik":null,"personType":"PN","sharesOwned":733633,"percentOfClass":7.8,"filedAt":"2026-01-05","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000902664-26-000037","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-23","reportingPerson":"Weston Nichols","reportingCik":null,"personType":"IN","sharesOwned":733633,"percentOfClass":7.8,"filedAt":"2026-01-05","canonicalUrl":"https://xoomar.com/markets/stocks/krro"},{"accessionNo":"0000938206-25-000050","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001703647","issuerName":"Korro Bio, Inc.","ticker":"KRRO","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"DRIEHAUS CAPITAL MANAGEMENT LLC","reportingCik":null,"personType":"IA","sharesOwned":671981,"percentOfClass":7.16,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/krro"}],"updatedAt":"2026-11-05T06:06:08.352Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/krro","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}